Rosen law firm urges revance therapeutics, inc. (nasdaq: rvnc) stockholders to contact the firm for information about their rights

New york--(business wire)--rosen law firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of revance therapeutics, inc. (nasdaq: rvnc) between february 29, 2024 and december 6, 2024. revance describes itself as a “biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the u.s. and internationally.” for more information, submit a form, em.
RVNC Ratings Summary
RVNC Quant Ranking